HMC Capital Zukünftiges Wachstum

Future Kriterienprüfungen 5/6

HMC Capital wird ein jährliches Gewinn- und Umsatzwachstum von 20.2% bzw. 21.8% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 19.7% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 9.5% betragen.

Wichtige Informationen

20.2%

Wachstumsrate der Gewinne

19.7%

EPS-Wachstumsrate

Capital Markets Gewinnwachstum	11.9%
Wachstumsrate der Einnahmen	21.8%
Zukünftige Eigenkapitalrendite	9.5%
Analystenabdeckung	Good
Zuletzt aktualisiert	28 Oct 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Gewinn- und Umsatzwachstumsprognosen

CHIA:HMC - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (AUD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
6/30/2027	273	184	158	165	6
6/30/2026	243	158	136	144	6
6/30/2025	220	133	121	129	6
6/30/2024	94	66	26	26	N/A
3/31/2024	88	61	21	21	N/A
12/31/2023	82	55	16	16	N/A
9/30/2023	85	56	8	8	N/A
6/30/2023	87	57	0	0	N/A
3/31/2023	110	53	-3	-3	N/A
12/31/2022	132	49	-6	-6	N/A
9/30/2022	149	63	-2	-2	N/A
6/30/2022	167	77	2	2	N/A
3/31/2022	146	35	6	6	N/A
12/31/2021	125	-7	11	11	N/A
9/30/2021	102	-53	17	17	N/A
6/30/2021	79	-100	23	23	N/A
3/31/2021	72	-68	18	18	N/A
12/31/2020	66	-36	13	13	N/A
9/30/2020	64	-15	-5	-5	N/A
6/30/2020	62	6	-23	-23	N/A
3/31/2020	60	-8	-40	-40	N/A
12/31/2019	57	-21	-57	-57	N/A
9/30/2019	53	-22	-54	-54	N/A
6/30/2019	49	-23	-50	-50	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: HMCDas prognostizierte Gewinnwachstum (20.2% pro Jahr) liegt über der Sparquote (2.4%).

Ertrag vs. Markt: HMCDie Erträge des Unternehmens (20.2% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Australian (12.3% pro Jahr).

Hohe Wachstumserträge: HMCEs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.

Einnahmen vs. Markt: HMCDie Einnahmen des Unternehmens (21.8% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Australian (5.7% pro Jahr).

Hohe Wachstumseinnahmen: HMCDie Einnahmen des Unternehmens (21.8% pro Jahr) werden voraussichtlich schneller wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: HMCDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (9.5%).

HMC Capital Zukünftiges Wachstum

Future Kriterienprüfungen 5/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Forecast breakeven pushed back to 2022

Home Consortium Limited Reaffirms FFO Guidance for the Fiscal Year 2021

Recent updates

HMC Capital Limited (ASX:HMC) entered into an agreement to acquire Global Switch Australia Holdings Pty Limited from Global Switch Holdings Limited for AUD 2.1 billion.

HMC Capital Limited has completed a Follow-on Equity Offering in the amount of AUD 300.000006 million.

HMC Capital Limited has filed a Follow-on Equity Offering in the amount of AUD 300.000006 million.

HMC Capital Limited, Annual General Meeting, Nov 27, 2024

HMC Capital Limited (ASX:HMC) acquired Market Central Lutwyche from Abacus Group (ASX:ABG) and ISPT Retail Australia Property Trust managed by ISPT Pty Ltd for approximately AUD 120 million.

Final dividend of AU$0.06 announced

HMC Capital Limited Announces Ordinary Dividend for the Six Months Ended June 30, 2024, Payable on October 2, 2024

Full year 2024 earnings released: EPS: AU$0.19 (vs AU$0.18 in FY 2023)

HMC Capital Limited to Report Fiscal Year 2024 Results on Aug 21, 2024

HMC Capital Limited (ASX:HMC) completed the acquisition of Payton Capital Ltd

New minor risk - Shareholder dilution

HMC Capital Limited has completed a Follow-on Equity Offering in the amount of AUD 100.000004 million.

HMC Capital Limited has filed a Follow-on Equity Offering in the amount of AUD 30.000003 million.

Now 20% undervalued

First half dividend of AU$0.06 announced

First half 2024 earnings released: FFO per share: AU$0.2 (vs AU$0.084 in 1H 2023)

HMC Capital Limited to Report First Half, 2024 Results on Feb 20, 2024

Investor sentiment improves as stock rises 18%

Insufficient new directors

Now 20% undervalued after recent price drop

HMC Capital Limited (ASX:HMC) and HealthCo Healthcare and Wellness REIT (ASX:HCW) completed the acquisition of Healthscope Portfolio from Medical Properties Trust, Inc. (NYSE:MPW).

HMC Capital Limited, Annual General Meeting, Nov 15, 2023

Now 20% undervalued

HMC Capital Limited Announces Ordinary Dividend for the Six Months Ended June 30, 2023, Payable on October 4, 2023

Full year 2023 earnings released: EPS: AU$0.18 (vs AU$0.26 in FY 2022)

HMC Capital Limited to Report Fiscal Year 2023 Results on Aug 23, 2023

Independent Non-Executive Director recently bought AU$250k worth of stock

First half 2023 earnings released: FFO per share: AU$0.08 (vs AU$0.10 in 1H 2022)

Now 21% undervalued

HMC Capital Limited to Report First Half, 2023 Results on Feb 23, 2023

Home Consortium Limited Announces Board Changes

Insufficient new directors

Home Consortium Limited, Annual General Meeting, Nov 23, 2022

Full year 2022 earnings released: EPS: AU$0.26 (vs AU$0.37 loss in FY 2021)

Home Consortium Limited Announces Ordinary Dividend for the Six Months Ended June 30, 2022, Payable on October 7, 2022

Home Consortium Limited to Report Fiscal Year 2022 Results on Aug 24, 2022

Home Consortium Limited's wholly owned subsidiary HMC Investment Management Limited Launches HMC Capital Partners Fund 1

High number of new and inexperienced directors

First half 2022 earnings: EPS in line with analyst expectations despite revenue beat

Home Consortium Limited Announces Dividend for the Six Months Ended December 31, 2021, Payable on April 7, 2022

Home Consortium Limited (ASX:HMC) agreed to acquire Aventus Group (ASX:AVN).

Home Consortium Limited to Report First Half, 2022 Results on Feb 24, 2022

Now 20% undervalued after recent price drop

MD, CEO & Director recently bought AU$501k worth of stock

High number of new and inexperienced directors

Key Executive recently bought AU$151k worth of stock

Independent Non-Executive Director recently bought AU$125k worth of stock

Full year 2021 earnings released

Home Consortium Limited (ASX:HMC) acquired portfolio of 8 private oncology assets from Genesis Care Pty Ltd for approximately AUD 110 million.

Forecast breakeven pushed back to 2022

Home Consortium Limited (ASX:HMC) entered into an agreement to acquire Five Dock (Childcare), NSW for AUD 13.1 million.

Home Consortium Limited Reaffirms FFO Guidance for the Fiscal Year 2021

Revenue beats expectations

First half 2021 earnings released: FFO AU$0.082 per share (vs AU$0.075 loss in 1H 2020)

New 90-day low: AU$3.76

Home Consortium Limited to Report First Half, 2021 Results on Feb 24, 2021

Home Consortium Limited (ASX:HMC) agreed to acquire Portfolio of 6 health, education and Government services properties for approximately AUD 130 million.

New 90-day high: AU$4.24

Home Consortium Limited Elects Kelly Odwyer as Director

New 90-day high: AU$3.63

Christopher Saxon to Assume the Role of Independent Chairman of Home Consortium Limited from 1 January 2021

New 90-day high: AU$3.44

Home Consortium Limited (ASX:HMC) signed binding contract to acquire Glenmore Park Town Centre in Australia for AUD 150 million.

Home Consortium Limited Announces Executive Appointments

New 90-day high: AU$3.25

New 90-day high - AU$3.23

Home Consortium Limited (ASX:HMC) completed the acquisition of 100% freehold interest in Prestons Place and Rosenthal Shopping Centre and 87.4% freehold interest in Vincentia Marketplace from Woolworths Group Limited (ASX:WOW).

Home Consortium Limited has completed a Follow-on Equity Offering in the amount of AUD 10.6408 million.

Home Consortium Limited to Report Fiscal Year 2020 Results on Aug 26, 2020

Gewinn- und Umsatzwachstumsprognosen

Analystenprognosen zum zukünftigen Wachstum

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite